President and Chief Executive Officer
Ilya Mazo, Ph.D. is President and chief executive officer (CEO) of Ariadne. Since his appointment, Mazo has grown Ariadne’s business by establishing leadership in key technology sectors of the bioinformatics industry and aggressively pursuing new market opportunities. Ariadne was founded in 2002 with a unique combined experience in software development for genomics and proteomics with talents and expertise in algorithm design, commercial bioinformatics system construction and bench-level biological expertise. Ariadne has strengthened its business and product offerings through partnership with best-of-breed technology vendors including Affymetrix, Illumina, BioBase, Algynomics, Accelerys, Prolexys and Microsoft.
Prior to his appointment, Mazo was Scientific Project Manager at InforMax where he launched several gene expression and PPI products and Research Scientist at CLONTECH where he developed the first commercial retroviral system.
Mazo received his Ph.D. in Genetics from the University of Illinois, Chicago in 1996 and a Master’s degree in biophysics from the Moscow Institute for Physics and Technology in 1989.